Home > Healthcare > Medical Devices > Diagnostic Devices > dermal toxicity testing market
Get a free sample of Dermal Toxicity Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Dermal Toxicity Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The dermal toxicity testing industry is fragmented, with key players including Eurofins Scientific, MatTek Corporation and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares. For instance, on September 14, 2023, MatTek expanded its culture ware range by introducing Ultra Low Attachment (ULA) Spheroid Plates for advanced spheroid cell culture applications. These plates, offered in collaboration with faCellitate, are sold under the BIOFLOAT brand in both 96-well and 384-well formats, thereby enhancing sales of dermal toxicity testing benefitting the industry players.
Some of the eminent market participants operating in the dermal toxicity testing industry include:
The in-vitro testing segment had a market share of over 42% in 2022 and will grow through 2032 due to advancements in cell culture technologies that have improved the reliability and relevance of in-vitro models.
The dermal toxicity testing industry was valued at USD 2.1 billion in 2022 and is estimated to reach USD 4.5 billion by 2032 as there is a growing recognition of the ethical concerns associated with the use of animals in testing procedures.
QIMA LTD, Charles River Laboratories, Evotec, MatTek Corporation, Eurofins Scientific, SGS Group, Intertek Group, InVivo Biosystems, Eurofins Scientific, and Qiagen N.V.
U.S. dermal toxicity testing market accounted for over USD 1.9 billion in 2022 and is predicted to witness substantial growth through 2032 owing to an increased emphasis on alternatives to traditional animal testing methods.